Literature DB >> 20020265

The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.

Ian M Copple1, Christopher E Goldring, Neil R Kitteringham, B Kevin Park.   

Abstract

Adverse drug reactions pose a significant public health problem. In some cases, the process of drug metabolism can contribute to the onset of toxicity through the bioactivation of a parent molecule to a chemically reactive intermediate. In order to maintain a favorable balance between bioactivation and detoxification, mammalian cells have evolved an inducible cell defense system known as the antioxidant response pathway. The activity of this cytoprotective pathway is largely regulated by the transcription factor Nrf2, which governs the expression of many phase II detoxification and antioxidant enzymes. In turn, the activity of Nrf2 is regulated by the cysteine-rich cytosolic inhibitor Keap1, which acts as a "sensor" for chemical/oxidative stress. This article summarizes our current understanding of the molecular mechanisms that regulate the function of the Keap1-Nrf2 pathway and highlights the importance of Nrf2 in the protection against drug-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20020265     DOI: 10.1007/978-3-642-00663-0_9

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  33 in total

Review 1.  Molecular mechanisms underlying chemical liver injury.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Expert Rev Mol Med       Date:  2012-02-03       Impact factor: 5.600

Review 2.  Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.

Authors:  Noori Al-Waili; Hamza Al-Waili; Thia Al-Waili; Khelod Salom
Journal:  Redox Rep       Date:  2017-03-09       Impact factor: 4.412

3.  Activation of Keap1/Nrf2 signaling pathway by nuclear epidermal growth factor receptor in cancer cells.

Authors:  Longfei Huo; Chia-Wei Li; Tzu-Hsuan Huang; Yung Carmen Lam; Weiya Xia; Chun Tu; Wei-Chao Chang; Jennifer L Hsu; Dung-Fang Lee; Lei Nie; Hirohito Yamaguchi; Yan Wang; Jingyu Lang; Long-Yuan Li; Chung-Hsuan Chen; Lopa Mishra; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

4.  Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity.

Authors:  Karen C Thomas; Manivannan Ethirajan; Kiumars Shahrokh; Hao Sun; Jeewoo Lee; Thomas E Cheatham; Garold S Yost; Christopher A Reilly
Journal:  J Pharmacol Exp Ther       Date:  2011-02-22       Impact factor: 4.030

5.  Reporter protein complementation imaging assay to screen and study Nrf2 activators in cells and living animals.

Authors:  Kunka Mohanram Ramkumar; Thillai Veerapazham Sekar; Kira Foygel; Bhakkiyalakshmi Elango; Ramasamy Paulmurugan
Journal:  Anal Chem       Date:  2013-07-23       Impact factor: 6.986

6.  Challenging oneself intermittently to improve health.

Authors:  Mark P Mattson
Journal:  Dose Response       Date:  2014-10-20       Impact factor: 2.658

7.  18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation.

Authors:  Ayman M Mahmoud; Hussein S Al Dera
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

Review 8.  Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria.

Authors:  Derick Han; Lily Dara; Sanda Win; Tin Aung Than; Liyun Yuan; Sadeea Q Abbasi; Zhang-Xu Liu; Neil Kaplowitz
Journal:  Trends Pharmacol Sci       Date:  2013-02-28       Impact factor: 14.819

9.  In vitro and in vivo characterization of a tunable dual-reactivity probe of the Nrf2-ARE pathway.

Authors:  Rui Wang; Daniel E Mason; Keith P Choe; Alfred S Lewin; Eric C Peters; Hendrik Luesch
Journal:  ACS Chem Biol       Date:  2013-06-17       Impact factor: 5.100

10.  Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy.

Authors:  Sankaranarayanan Kannan; Vasanthi R Muthusamy; Kevin J Whitehead; Li Wang; Aldrin V Gomes; Sheldon E Litwin; Thomas W Kensler; E Dale Abel; John R Hoidal; Namakkal S Rajasekaran
Journal:  Cardiovasc Res       Date:  2013-06-12       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.